Viewing Study NCT06714266


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-24 @ 4:01 PM
Study NCT ID: NCT06714266
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-03
First Post: 2024-11-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor: Shandong Cancer Hospital and Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module